Rytary (levodopa/carbidopa extended-release capsule) / Amneal  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rytary (levodopa/carbidopa extended-release capsule) / Amneal
APEX-PD, NCT00880620 / 2009-010193-38: A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease

Checkmark
Nov 2013 - Nov 2013: 
Completed
3
381
Europe, Canada, US, RoW
Placebo, IPX066 95 mg LD, CD-LD ER 95 mg, IPX066 145 mg LD, CD-LD ER 145 mg, IPX066 195 mg LD, CD-LD ER 195 mg, IPX066 245 mg LD, CD-LD ER 245 mg
Impax Laboratories, LLC
Parkinson's Disease
10/10
11/10
NCT00974974 / 2009-014688-37: A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).

Checkmark
Mar 2016 - Mar 2016: 
Checkmark
Mar 2016 - Mar 2016: 
Checkmark
More
Completed
3
471
Europe, Canada, US, RoW
IPX066, ER CD-LD, IR CD-LD, immediate-release carbidopa-levodopa
Impax Laboratories, LLC
Parkinson's Disease
01/11
03/11
NCT01096186 / 2009-017182-38: An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

Checkmark
Mar 2013 - Mar 2013: 
Completed
3
617
Europe, Canada, US, RoW
IPX066 95 mg, CD-LD ER 95 mg, IPX066 145 mg, CD-LD ER 145 mg, IPX066 195 mg, CD-LD ER195 mg, IPX066 245 mg, CD-LD ER 245 mg
Impax Laboratories, LLC
Parkinson's Disease
10/11
10/11
NCT01130493 / 2009-017238-39: A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Checkmark Parkinson's disease
Oct 2014 - Oct 2014: Parkinson's disease
Checkmark AAN-2012 Data
Mar 2012 - Mar 2012: AAN-2012 Data
Checkmark P3 data, PD, idiopathic, advanced, on stable dopaminergic Rx
More
Completed
3
110
Europe, US
IPX066, extended-release carbidopa-levodopa, CLE, carbidopa/levodopa/entacapone
Impax Laboratories, LLC
Parkinson's Disease
01/12
01/12
NCT01411137: Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study

Checkmark
Jun 2013 - Jun 2013: 
Completed
3
43
US
IPX066, ER CD-LD
Impax Laboratories, LLC, Michael J. Fox Foundation for Parkinson's Research
Parkinson's Disease
03/13
03/13

Download Options